Literature DB >> 9038566

Quality of life following resection of oesophageal carcinoma.

H U Zieren1, C A Jacobi, J Zieren, J M Müller.   

Abstract

Quality of life following resection of oesophageal carcinoma was assessed by patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and by a psychologist using the Spitzer Index. Quality of life was evaluated in 119 patients on one occasion 12 months after operation and in 30 patients regularly, starting with a preoperative assessment. Self and external evaluation showed a significant correlation (r = 0.61), but quality of life was assessed as being higher by the external observer. Limited physical performance status and somatic complaints were the most important postoperative dysfunctions, whereas emotional, social and economic disorders were found to be less frequent and less severe. Of several factors analysed only tumour recurrence (P < 0.01) and anastomotic stricture (P < 0.05) lowered quality of life significantly. Compared with the preoperative assessment, quality of life had decreased on discharge from hospital but was restored within 6 months of operation in disease-free patients. Further studies are required to determine the impact of adjuvant therapy for quality of life in patients undergoing surgery for oesophageal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 9038566     DOI: 10.1002/bjs.1800831235

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Digestive tract reconstruction pattern as a determining factor in postgastrectomy quality of life.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Kun Yang; Jian-Kun Hu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection.

Authors:  Pernilla Viklund; Mats Lindblad; Jesper Lagergren
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  The prognostic value of quality of life scores during treatment for oesophageal cancer.

Authors:  J M Blazeby; S T Brookes; D Alderson
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

5.  Long-term health-related quality of life for disease-free esophageal cancer patients.

Authors:  Claire L Donohoe; Erin McGillycuddy; John V Reynolds
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

6.  Long-Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy.

Authors:  E Jezerskyte; L M Saadeh; E R C Hagens; M A G Sprangers; L Noteboom; H W M van Laarhoven; W J Eshuis; M I van Berge Henegouwen; S S Gisbertz
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

7.  Comparative experience of open and minimally invasive esophagogastric resection.

Authors:  Rajeev Parameswaran; Darmarajah Veeramootoo; Rakesh Krishnadas; Martin Cooper; Richard Berrisford; Shahjehan Wajed
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

8.  Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses.

Authors:  Christian E Schmidt; Beate Bestmann; Thomas Küchler; Andreas Schmid; Bernd Kremer
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

9.  Endoscopic intubation with conventional plastic stents: a safe and cost-effective palliation for inoperable esophageal cancer.

Authors:  Károly Szentpáli; András Palotás; György Lázár; Attila Paszt; Adám Balogh
Journal:  Dysphagia       Date:  2004       Impact factor: 3.438

10.  Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

Authors:  E M L Verschuur; E W Steyerberg; H W Tilanus; S Polinder; M-L Essink-Bot; K T C Tran; A van der Gaast; L P S Stassen; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.